Electro Optic Systems Holdings Ltd (EOS)
Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026
Key indicators
| Last close | AUD 8.980 |
|---|---|
| 52-week range | 4.270 – 12.910 |
| Return, 1 month / 3 months | −20.7% / +20.5% |
| Return, 1 year / 3 years | +46.5% / +903.4% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 93.6% |
| Worst drawdown (1 year) | -50.2% |
| Average daily value traded | 27.03M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Electro Optic Systems Holdings is an Australian technology company that designs and builds electro-optic and laser-based systems for defence and space uses. Its products include remote weapon stations, high-energy laser systems, space surveillance and tracking services, and satellite laser ranging and communications equipment. Customers are mainly defence forces, government agencies and space organisations, served from facilities in Australia and the United States. The company is based in Canberra, Australia.
Electro Optic Systems Holdings Ltd trades under the code EOS on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Electro Optic Systems Holdings Ltd (EOS) trades on the Australian Securities Exchange in Australia. It last closed at AUD 8.980 on 27 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 357 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 46.5% and over the last three months it rose 20.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -2.4% | ||
| From 52-week high | -26.8% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.5% | ||
| 6-month return | -12.3% | ||
| 12-month return, skipping the last month | 84.7% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 93.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.2% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 27.03M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −20.7% |
| 3 months | +20.5% |
| 6 months | −12.3% |
| 1 year | +46.5% |
| 3 years | +903.4% |
| 5 years | +163.3% |
Signals
| 50-day / 200-day average | 9.916 / 9.200 |
|---|---|
| Golden / death cross (60 days) | Golden, 17 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.765 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.